PDF Cover

Viscoelastic Coagulation Testing Market

The market for Viscoelastic Coagulation Testing was estimated at $872 million in 2024; it is anticipated to increase to $1.41 billion by 2030, with projections indicating growth to around $2.12 billion by 2035.

Report ID:DS1801400
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Viscoelastic Coagulation Testing
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Viscoelastic Coagulation Testing Market Outlook

Revenue, 2024

$872M

Forecast, 2034

$1.95B

CAGR, 2025 - 2034

8.4%

The Viscoelastic Coagulation Testing industry revenue is expected to be around $944.7 million in 2025 and expected to showcase growth with 8.4% CAGR between 2025 and 2034. The substantial expansion of the Viscoelastic Coagulation Testing market can be credited to important reasons. The rising occurrence of coagulation abnormalities like hemophilia and Von Willebrand disease has notably spurred the need for diagnostic options. Moreover the continuous progress in coagulation testing technology along with increased knowledge, about early disease identification has additionally boosted the markets significance in the healthcare industry. The increasing demand for precise testing techniques in trauma situations and surgical procedures is another key driver, behind the markets growth.

Viscoelastic coagulation testing is a diagnostic method that offers detailed insights into how blood clotting occurs in the body. It is commonly employed to evaluate the clotting function in patients undergoing surgical procedures and those with traumatic injuries or coagulation issues. This testing approach is recognized for its capability to offer thorough evaluations of the entire clotting process. From the formation of clots, to their breakdown.

Viscoelastic Coagulation Testing market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Viscoelastic Coagulation Testing Market Outlook

Market Key Insights

  • The Viscoelastic Coagulation Testing market is projected to grow from $871.5 million in 2024 to $1.95 billion in 2034. This represents a CAGR of 8.4%, reflecting rising demand across Trauma Surgery, Cardiac Surgery, and Obstetrics.

  • Werfen Group, Haemonetics Corporation, Siemens Healthineers are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Viscoelastic Coagulation Testing market and are expected to observe the growth CAGR of 6.1% to 8.8% between 2024 and 2030.

  • Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 8.1% to 10.5%.

  • Transition like Automation in Viscoelastic Coagulation Testing is expected to add $50 million to the Viscoelastic Coagulation Testing market growth by 2030.

  • The Viscoelastic Coagulation Testing market is set to add $1.1 billion between 2024 and 2034, with manufacturer targeting Diagnostic Laboratories & Research Institutes Application projected to gain a larger market share.

  • With

    increasing prevalence of coagulation disorders, and

    Advancements in Viscoelastic Devices, Viscoelastic Coagulation Testing market to expand 124% between 2024 and 2034.

viscoelastic coagulation testing market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Viscoelastic Coagulation Testing - Country Share Analysis

Opportunities in the Viscoelastic Coagulation Testing

Advanced technologies in healthcare are also making strides with Viscoelastic Coagulation Testing solutions on the horizon thanks to AI and ML integration to improve the accuracy and efficiency of these tests, for healthcare professionals and patients alike.

Growth Opportunities in North America and Asia-Pacific

North America holds importance for Viscoelastic Coagulation Testing with a strong healthcare system and a high incidence of coagulation disorders. Particularly in the United States region specifically known for its advancements in coagulation testing devices due to the rise in surgical procedures that necessitate preoperative and postoperative coagulation assessments. Moreover the region benefits from having market players providing state of the art solutions, for Viscoelastic Coagulation Testing. The steep price of these examinations might hinder the expansion of the market.
The market for Viscoelastic Coagulation Testing in the Asia Pacific region is experiencing expansion primarily because of the rising prevalence of coagulation disorders and the increasing number of elderly individuals in the population. Countries like China and India are emerging as centers of demand owing to enhancements in healthcare infrastructure and heightened awareness regarding coagulation disorders. The local presence of manufacturers in the region is also impacting the market by fostering competition and encouraging innovation. Despite promising opportunities in this sector a lack of awareness and restricted access to testing options pose significant challenges, in certain region's.

Market Dynamics and Supply Chain

01

Driver: Increasing Prevalence of Coagulation Disorders, and Growing Demand for Personalized Medicine

The increasing occurrence of blood clotting issues like Hemophilia and Von Willebrand disease plays a role in the market, for Viscoelastic Coagulation Testing products and services. This of testing offers an evaluation of the body blood clotting process and aids doctors in diagnosing and treating these disorders efficiently. The increasing need for customized healthcare is also also driving the growth of the Viscoelastic Coagulation Testing market as these tests provide information, about a patients blood clotting status leading to tailored treatment plans and better patient results.
The progress in tools like automated and portable devices has also increased the accessibility and user friendliness of Viscoelastic Coagulation Testing significantly. These developments have also broadened the application of these tests, across healthcare environments. From hospitals to point of care testing. Fuelin market expansion.
02

Restraint: High Cost of Viscoelastic Coagulation Testing

One of the challenges in the market is the significant expense associated with viscoelastic coagulation testing procedures due to the advanced technology involved and the need for specialized training required to conduct these tests effectively; this makes them less accessible in regions with limited healthcare budgets like developing countries where resources are already stretched thin. The costly nature of these tests not only hinders their widespread adoption but also plays a pivotal role in shaping the market dynamics by influencing healthcare providers purchasing decisions and subsequently impacting the overall demand, for viscoelastic coagulation testing services.
03

Opportunity: Expansion into Emerging Markets and Strategic Collaborations to Enhance Market Presence

The market for Viscoelastic Coagulation Testing shows promising growth opportunities in developing countries with expanding economies like India, China and Brazil experiencing a rise in healthcare spending and a growing number of cases involving coagulation disorders. This provides a chance, for Viscoelastic Coagulation Testing providers to broaden their reach and address the healthcare needs that remain unmet in these areas.
Building partnerships and working closely with healthcare institutions and research organizations can enhance the visibility of Viscoelastic Coogulation Testing providers in the market space. Through these collaborations there is an opportunity to support research efforts and drive innovation which can result in the launch of enhanced testing options, for consumers.
04

Challenge: Lack of Awareness and Limited Accessibility

In the viscoelastic coagulation testing market a notable issue is the lack of knowledge regarding the advantages of these tests among practitioners and patients alike. In areas including rural and underprivileged regions there exists a scarcity of access to sophisticated diagnostic instruments such, as viscoelastic coagulation testing tools.

Supply Chain Landscape

1

Raw Material Suppliers

BASF SEDow Chemical Company
2

Component Manufacturers

Siemens HealthineersHaemonetics Corporation
3

Assembly & Testing

Werfen GroupStago Group
4

End Users

HospitalsDiagnostic LaboratoriesResearch Institutes
Viscoelastic Coagulation Testing - Supply Chain

Use Cases of Viscoelastic Coagulation Testing in Trauma Surgery & Cardiac Surgery

Trauma Surgery : Viscoelastic coagulation testing, such as Thromboelastography and ROTEM, is commonly utilized in trauma surgery to effectively evaluate a patient’s coagulation status and assist surgeons in making informed decisions regarding the administration of blood products. Leading players in this field include Haemonetics Corporation and Werfen, both recognized for their cutting-edge testing technologies and significant market influence.
Cardiac Surgery : Cardiac surgery heavily relies on Viscoelastic Coagulation Testing to control bleeding during the perioperative period. TEG and ROTEM tests are instrumental in providing updates on coagulation levels to minimize transfusions and potential risks involved. Siemens Healthineers and Stago stand out as players, in this sector known for their advanced coagulation testing products and strong market presence.
Obstetrics : Viscoelastic Coagulation Testing is commonly utilized in obstetrics for addressing postpartum hemorrhage—a contributor to maternal mortality globally. The TEG and ROTEM assessments offer practical information on a patients coagulation condition to facilitate prompt intervention. Essential contributors, in this field are Instrumentation Laboratory and Roche Diagnostics known for their top notch testing devices and substantial market presence.

Recent Developments

The demand for Viscoelastic Coagulation Testing in the healthcare industry has seen a notable increase lately due to its growing use in diagnosing and treating coagulation related conditions—a prominent trend, in the market.

December 2024 : Roche Diagnostics introduced a cutting edge viscoelastic coauglation testing tool that offers accuracy and quicker outcomes.
October 2024 : Sysystemex Corporation implemented AI driven data analysis to enhance the accuracy of viscoelastic coagulation testing, for diagnosis outcomes.
August 2024 : Siemens Healthineers revealed a new collaboration with Medtronic to enhance healthcare through advancements, in viscoelastic coa­gulation testing.

Impact of Industry Transitions on the Viscoelastic Coagulation Testing Market

As a core segment of the Medical Device industry, the Viscoelastic Coagulation Testing market develops in line with broader industry shifts. Over recent years, transitions such as Automation in Viscoelastic Coagulation Testing and Integration of AI have redefined priorities across the Medical Device sector, influencing how the Viscoelastic Coagulation Testing market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Automation in Viscoelastic Coagulation Testing

The introduction of automation in viscoelastic coagulation testing has marked a shift within the industry landscape. Automatic viscoelastic testing tools have transformed the approach to conducting coagulation tests by increasing efficiency and precision. These devices have notably shortened sample processing time which speeds up procedures. Moreover automation has reduced the chances of errors leading to greater reliability in test outcomes. This change has left an imprint, on the healthcare sector especially in critical care and trauma centers where rapid and precise coagulation tests are vital.
02

Integration of AI

AI has been seamlessly incorporated into the field of viscoelastic coagulation testing—a shift indeed! Cutting edge AI algorithms now play a role in deciphering intricate coagulation test outcomes to aid healthcare practitioners in their decision making processes with greater ease and accuracy. This advancement not only enhances diagnostic precision but also streamlines patient treatment protocols considerably. The integration of AI marks a moment, in the medical technology sector as it sparks innovation and propels growth within the domain of coagulation testing devices.